In addition, we compared the percentages of protection and the levels of change of the IL-4 targets in CLL, and found significant correlations, pointing out new potential anti-apoptotic players, of which HOMER2 and BCL6 had the highest increases (Table 2). The gene discussed is HOMER2; the disease is B-cell chronic lymphocytic leukemia.